Australian biotech company Noxopharm (ASX:NOX) has announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to Veyonda®, its lead oncology drug candidate, for...
Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its Phase 1 CEP-2 sarcoma trial is underway with a first patient enrolled and dosed at City of Hope in Los...
Exclusive deal for cutting-edge RNA technology in drug discovery and vaccines Australian clinical-stage drug development company Noxopharm (ASX:NOX) has in-licensed novel RNA technology...
Experimental Immunotherapy Cancer Treatment Enters Phase 2 Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its DARRT-2 Phase 2 clinical trial has commenced...
(ビジネスワイヤ) -- オーストラリアの臨床段階医薬品開発企業であるノクソファーム(ASX:NOX)は、治験薬の抗がん剤でビヨンダの有効成分となっているイドロノキシルが、早期COVID-19の治療における抗炎症薬...
La société australienne de développement de médicaments de stade clinique, Noxopharm (ASX : NOX) a publié des données précliniques qui viennent confirmer le rôle de l’idronoxil, médicament...
Australian clinical-stage drug development company Noxopharm (ASX:NOX) has reported preclinical data that further supports the role of experimental anti-cancer drug, idronoxil, the active...
第1相臨床試験の良好な結果を受けて、臨床プログラムを世界に拡大へ (ビジネスワイヤ) -- オーストラリアの臨床段階医薬品開発企業であるノクソファーム(ASX:NOX)は、TBK1(TANK結合キナーゼ1)阻害剤で...
Le programme clinique est développé à l’échelle mondiale suite aux résultats cliniques positifs de phase I La société australienne de développement de médicaments de stade clinique, Noxopharm...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.023 | 29.8701298701 | 0.077 | 0.1 | 0.077 | 162200 | 0.08651411 | DE |
4 | 0.001 | 1.0101010101 | 0.099 | 0.1 | 0.075 | 122792 | 0.08578891 | DE |
12 | -0.03 | -23.0769230769 | 0.13 | 0.135 | 0.075 | 137352 | 0.10073405 | DE |
26 | 0.03 | 42.8571428571 | 0.07 | 0.15 | 0.068 | 249160 | 0.10581463 | DE |
52 | 0.033 | 49.2537313433 | 0.067 | 0.15 | 0.051 | 205233 | 0.09274643 | DE |
156 | -0.27 | -72.972972973 | 0.37 | 0.495 | 0.033 | 346340 | 0.12891973 | DE |
260 | -0.145 | -59.1836734694 | 0.245 | 0.99 | 0.033 | 511195 | 0.33716814 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.